Madison Avenue International LP 13D and 13G filings for Ovid Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:41 pm Sale |
2024-12-31 | 13G | Ovid Therapeutics Inc. OVID |
Madison Avenue International LP | 2,852,352 4.000% |
-796,157 (-21.82%) |
Filing |
| 2024-02-14 11:10 am Purchase |
2023-12-31 | 13G | Ovid Therapeutics Inc. OVID |
Madison Avenue International LP | 3,648,509 5.200% |
39,455 (+1.09%) |
Filing |
| 2023-07-31 5:21 pm Purchase |
2023-07-20 | 13G | Ovid Therapeutics Inc. OVID |
Madison Avenue International LP | 3,609,054 5.100% |
3,609,054 (New Position) |
Filing |